Elsevier

The Surgeon

Volume 14, Issue 6, December 2016, Pages 345-360
The Surgeon

The management of osteomyelitis in the adult

https://doi.org/10.1016/j.surge.2015.12.005Get rights and content

Abstract

Background and purpose

Osteomyelitis (OM) is considered one of the most challenging medical conditions an orthopaedic surgeon has to face. Much debate is present concerning diagnosis and treatment, especially about differences between acute and chronic forms of the condition. The main aim of the present work is to show the key points where research should be implemented.

Methods

Online database were searched to find evidence about the clinical management of osteomyelitis. Clinical randomized trials, case series, prospective cohort studies reporting on diagnosis and treatment of acute and chronic osteomyelitis were taken into consideration. Cadaveric studies, laboratory studies, case reports, review articles and meta-analyses were excluded. Furthermore, studies concerning implant related OM were excluded. Studies in English, Spanish and French were considered in this process of inclusion. The cohorts of all the included studies were composed of adult patients.

Results

The main growpoints concerning OM are the identification of a correct laboratory test array to allow a prompt diagnosis and provide a sensitive and specific detection of the bacterial species involved, along with antibiotic drug resistance; optimal imaging techniques, according to the phase of the infection, have to be performed, to avoid unnecessary medical expenses; the identification of a suitable compromise between intravenous and oral drugs administration. A flow chart is proposed for optimal clinical management of this pathology.

Conclusion

More work should be carried out to clarify the main issues concerning the clinical management of osteomyelitis in adult patients.

Introduction

Osteomyelitis is one a most challenging condition for both physicians and patients, with an incidence of 21.8 per 100,000 person/years in the United States.1 It an inflammatory state of the bone caused by a microorganism; it can involve either the trabecular or the cortical bone, the bone marrow and the periosteum.2 Osteomyelitis can be generally classified in four categories: acute, chronic, diabetic foot related, and implant related, but several and more articulated classifications have been developed. A classification for osteomyelitis (OM) has been proposed by Waldvogel in 1970, based on the source of infection.3 Three different conditions have been considered: OM caused by local spreading from a contiguous focus of infection; OM secondary to vascular insufficiency (more likely to develop in the diabetic foot); and haematogenous OM, derived from a condition of bacteraemia.3 This classification is useful for pathological definition of the disease. A more clinical classification was developed by Cierny and Mader in 1983 for chronic OM.4 This classification is widely used in daily clinical practice, and has shown a good prognostic value. The main histo-pathological lesion of OM is the sequestrum, which consists in formation of necrotic bone, which lays in the midst of the infected tissue.2 A sequestrum derives from the destruction of bone tissue and bone matrix from inflammatory factors, including leucocytes and cytokines that increase the osteoclasts activity. Because of the lack of vascularization, and hence the impossibility to be reached by immunity cells and drugs, the sequestrum is the cause of persistent infection, since the pathogens are embedded in it. Several bacteria and fungi are common infecting microorganism. Staphylococcus aureus and Staphylococcus epidermidis are the most common pathogens, because of their presence in the normal flora of the skin. Other relevant bacteria are Enterococcus spp, Streptococcus spp; among the fungi, Candida5, 6 and Aspergillus6 have been reported.

The diagnosis of OM is using a multidisciplinary approach involving laboratory medicine, imaging, and pathology. Therapy is based on a multi-area treatment involving antibiotic drugs administration and surgery. The present review collected and analysed the recent scientific evidence about the epidemiology and clinical management of OM, giving an overview on the most common pathogens causing OM, diagnostic techniques and therapeutic options for acute and chronic OM.

Section snippets

Methods

An online search was performed to retrieve studies concerning the research topic. Medline (http://www.ncbi.nlm.nih.gov/pubmed), Cochrane (http://www.thecochranelibrary.com/view/0/index.html) and Google scholar (http://scholar.google.it/) were searched to retrieve studies published between 1990 and present. The following search key words have been used: “(“osteomyelitis”[MeSH Terms] OR “osteomyelitis”[All Fields]) AND (“therapy”[Subheading] OR “therapy”[All Fields] OR “treatment”[All Fields] OR

Results

To present a clear overview on results of the studies included, each section is divided considering the type of OM, among acute, chronic, and diabetes foot OM (DFO) (see Table 1).

Discussion

Osteomyelitis is common, and remains a challenge for both the surgeon and the patient. In the literature, debate is present concerning its treatment, while fewer studies focus on diagnostic methods. The normal skin flora is more likely to be the direct cause of OM than other pathogens. S. aureus and S. epidermidis5, 23 are the most common pathogens, together with Streptococci and gram negative bacteria which are common in organic secretions or are brought into the site of infection by foreign

Conclusion

The present article provides a general and updated overlook on osteomyelitis in adults, especially regarding diagnosis and treatment. A management flow chart is proposed in Fig. 1, showing the basic steps which should be followed for an evidence-based clinical approach to this condition. The lack of comparison studies and randomized controlled trials makes it difficult to have proper information about the relative efficacy of the different therapies. Furthermore, the heterogeneity of the design

Funding

No financial support has been received for the writing of the present piece of work.

References (46)

  • F.J. Aragon-Sanchez et al.

    Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement

    Diabetologia

    (2008)
  • A. Gupta et al.

    Long-term outcome of pyogenic vertebral osteomyelitis: a cohort study of 260 patients

    Open Forum Infect Dis

    (2014)
  • T. O'Brien et al.

    Acute haematogenous osteomyelitis

    J Bone Jt Surg Br

    (1982)
  • C.B. Howard et al.

    Fine-needle bone biopsy to diagnose osteomyelitis

    J Bone Jt Surg Br

    (1994)
  • C.B. Howard et al.

    Ultrasound in diagnosis and management of acute haematogenous osteomyelitis in children

    J Bone Jt Surg Br

    (1993)
  • R. Morales Lozano et al.

    Validating the probe-to-bone test and other tests for diagnosing chronic osteomyelitis in the diabetic foot

    Diabetes Care

    (2010)
  • B.M. Ertugrul et al.

    The diagnosis of diabetic foot osteomyelitis: examination findings and laboratory values

    Med Sci Monit

    (2009)
  • M. Michail et al.

    The performance of serum inflammatory markers for the diagnosis and follow-up of patients with osteomyelitis

    Int J Low Extrem Wounds

    (2013)
  • G. Uzun et al.

    Procalcitonin as a diagnostic aid in diabetic foot infections

    Tohoku J Exp Med

    (2007)
  • M.B. Tomas et al.

    The diabetic foot

    Br J Radiol

    (2000)
  • F. De Winter et al.

    Promising role of 18-F-fluoro-D-deoxyglucose positron emission tomography in clinical infectious diseases

    Eur J Clin Microbiol Infect Dis

    (2002)
  • O. Kagna et al.

    FDG PET/CT imaging in the diagnosis of osteomyelitis in the diabetic foot

    Eur J Nucl Med Mol Imaging

    (2012)
  • S.S. Lewis et al.

    Clinical utility of indium 111-labeled white blood cell scintigraphy for evaluation of suspected infection

    Open Forum Infect Dis

    (2014)
  • Cited by (81)

    • The Role of Hyperbaric Oxygen Therapy for the Treatment of Wounds

      2022, Physical Medicine and Rehabilitation Clinics of North America
      Citation Excerpt :

      Patients should reduce or skip morning insulin or oral hypoglycemics to reduce the risk of hypoglycemia during HBOT.22 Osteomyelitis is an inflammatory process affecting bone due to infiltration of the tissue by bacteria and involves all or some portion of the bone: periosteum, cortical bone, trabecular bone, and bone marrow.23,24 The Cierny Mader classification system grades osteomyelitis based on the extent of the affected bone.

    View all citing articles on Scopus
    View full text